Monroe Capital announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of ProPharma Group by private equity sponsor, Linden Capital Partners.
 
Founded in 2001 and based in Overland Park, KS, ProPharma is a leading provider of outsourced medical information, pharmacovigilance, and regulatory compliance consulting services to customers in the pharmaceutical, biotechnology, and medical device industries. The company has grown to a global organization operating five contact centers across the United States, Europe and Australia. ProPharma serves a customer base which includes many of the world’s largest and well-known biopharmaceutical companies.

Monroe Capital LLC is a leading provider of senior and junior debt and equity co-investments to middle-market companies in the U.S. and Canada. Investment types include unitranche financings, cash flow and enterprise value based loans, asset based loans, acquisition facilities, mezzanine debt, second lien or last-out loans and equity co-investments. Monroe has been recognized by Global M&A Network as the 2015, 2014, and 2013 Small Middle Markets Lender of the Year; Private Debt Investor as the 2015 Lower Mid-Market Lender of the Year, the 2014 Senior Lender of the Year, and the 2013 Unitranche Lender of the Year; and the U.S. Small Business Administration as the 2015 Small Business Investment Company (SBIC) of the Year.